Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Gaurav Aggarwal currently holds 1,789,915 shares of Unicycive Therapeutics, Inc. (UNCY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gaurav Aggarwal has been a net buyer of UNCY stock. They have purchased $21.7M and sold $0 worth of shares.
Gaurav Aggarwal's most recent insider trade was on Aug 25, 2025, when they sold 652,900 shares at $0.00 per share.
Gaurav Aggarwal serves as Executive at Unicycive Therapeutics, Inc. (UNCY). They have executed 12 insider transactions totaling $21.7M over their tenure at the company.
Gaurav Aggarwal holds the position of Executive at Unicycive Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
Gaurav Aggarwal has shown a buying trading pattern, with $21.7M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Gaurav Aggarwal was on Jul 1, 2022, when they sold $150.5M worth of SRRA shares. This transaction involved 2,735,853 shares at $55.00 per share.
Gaurav Aggarwal currently owns 1,789,915 shares of Unicycive Therapeutics, Inc. (UNCY), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Gaurav Aggarwal's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Gaurav Aggarwal has 12 Form 4 filings on record as an insider at Unicycive Therapeutics, Inc..
Set alerts for Gaurav Aggarwal and 40,000+ other insiders.